Whole Body Cryotherapy as an Adjunct for Depressive Symptoms

What is established

Whole body cryotherapy (WBC) involves brief exposure, typically two to three minutes, to extreme cold air in a chamber or cabin. It is widely used in sports medicine and general recovery settings, and its physiological effects, transient skin cooling, a catecholamine and cortisol response, and short-term changes in perceived pain and mood, are reasonably well characterized in that context.[1]

Using WBC as an add-on treatment for a diagnosed depressive episode is a different question from using it for recovery or wellness. That specific use has been tested in only a handful of small clinical trials, and independent reviewers who have assessed this literature describe it as an emerging idea, not an established psychiatric intervention.[2]

What the controlled trial actually found

The main evidence for this specific use is a Polish double-blind, sham-controlled trial. Of 92 adults with a depressive episode who were randomized, 56 completed the protocol of ten sessions over two weeks while continuing their prescribed antidepressant medication. The cryotherapy group showed a significantly larger drop in Hamilton Depression Rating Scale and Beck Depression Inventory-II scores than the sham group by the two-week follow-up, and 73% reached self-reported remission on the BDI-II compared with 28% in the sham group.[1]

The same trial, however, found that remission defined by clinician-rated Hamilton scores was not significantly different between groups (66.7% versus 57.1%), and several secondary measures, including sleep quality, vitality, and sexual satisfaction, showed no significant change relative to sham. None of the inflammatory or oxidative-stress markers measured, including CRP, IL-6, IL-10, nitric oxide, and total antioxidant status, differed significantly between groups, despite these being the mechanism the researchers proposed for how cryotherapy might help.[1]

Self-reported improvement did not match clinician-rated remission

A single trial with a clear positive headline result can still contain outcomes pointing in different directions. Here, the patient-completed questionnaire showed a large remission difference, while the clinician-administered scale, generally considered less prone to expectancy effects, showed a smaller and non-significant difference. The trial also delivered cryotherapy in a group setting, so social contact and attention cannot be separated from the cold exposure itself as a cause of any benefit.[1]

What remains uncertain

This is a single-center trial with substantial attrition, 92 people were randomized and only 56 completed treatment, and it has not been independently replicated. Two systematic reviews that pooled the available trials reached the same overall caution. One found large statistical effect sizes across the pooled studies but explicitly labeled the evidence preliminary and called for larger, better-controlled trials before any routine use. A separate review that applied formal quality screening found only three trials met its inclusion criteria and rated the underlying study quality as moderate at best, concluding that WBC for depression remains an unconfirmed, investigational approach.[3][2]

• No independent replication of the sham-controlled RCT result.
• Clinician-rated remission was not statistically significant in the same trial that reported significant self-rated remission.
• No significant change in any of the inflammatory or oxidative-stress markers proposed as the mechanism.
• Group-based delivery makes it difficult to separate a cold-exposure effect from a social-contact or attention effect.
• No trial has followed patients beyond two weeks after treatment.

What this means for you

AION treats this as an experimental adjunct, not a depression treatment in its own right. If you are on antidepressant medication and interested in cryotherapy, that is a conversation to have with, and something to keep managed by, your prescribing psychiatrist or physician, with cryotherapy considered only alongside, never instead of, your existing treatment plan.[1]

Because the evidence base is small and the mechanism unconfirmed, AION does not offer a fixed cryotherapy protocol for depression, does not present it as validated by biomarker change, and does not use it to replace psychiatric follow-up. Any decision to add it stays individualized and physician-led, with diagnostics and ongoing mental health care coming first.[2][3]